0000899243-19-017819.txt : 20190621 0000899243-19-017819.hdr.sgml : 20190621 20190621170837 ACCESSION NUMBER: 0000899243-19-017819 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190620 FILED AS OF DATE: 20190621 DATE AS OF CHANGE: 20190621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: King Sasha CENTRAL INDEX KEY: 0001721150 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36536 FILM NUMBER: 19912319 MAIL ADDRESS: STREET 1: C/O CAREDX, INC. STREET 2: 3260 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CareDx, Inc. CENTRAL INDEX KEY: 0001217234 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 943316839 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3260 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 415-287-2300 MAIL ADDRESS: STREET 1: 3260 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: XDx, Inc. DATE OF NAME CHANGE: 20071010 FORMER COMPANY: FORMER CONFORMED NAME: EXPRESSION DIAGNOSTICS INC DATE OF NAME CHANGE: 20030203 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-20 0 0001217234 CareDx, Inc. CDNA 0001721150 King Sasha C/O CAREDX, INC. 3260 BAYSHORE BOULEVARD BRISBANE CA 94005 0 1 0 0 Chief Commercial Officer Common Stock 2019-06-20 4 M 0 500 1.00 A 72772 D Common Stock 2019-06-20 4 M 0 417 1.07 A 73189 D Common Stock 2019-06-20 4 M 0 278 2.80 A 73467 D Common Stock 2019-06-20 4 M 0 1667 5.90 A 75134 D Common Stock 2019-06-20 4 M 0 833 6.31 A 75967 D Common Stock 2019-06-20 4 M 0 12500 12.24 A 88467 D Common Stock 2019-06-20 4 S 0 30840 38.3759 D 57627 D Employee Stock Option (right to buy) 1.00 2019-06-20 4 M 0 500 0.00 D 2027-04-21 Common Stock 500 5500 D Employee Stock Option (right to buy) 1.07 2019-06-20 4 M 0 417 0.00 D 2027-06-09 Common Stock 417 5000 D Employee Stock Option (right to buy) 2.80 2019-06-20 4 M 0 278 0.00 D 2027-09-01 Common Stock 278 3750 D Employee Stock Option (right to buy) 5.90 2019-06-20 4 M 0 1667 0.00 D 2027-10-27 Common Stock 1667 23333 D Employee Stock Option (right to buy) 6.31 2019-06-20 4 M 0 833 0.00 D 2028-01-19 Common Stock 833 12917 D Employee Stock Option (right to buy) 12.24 2019-06-20 4 M 0 12500 0.00 D 2028-06-29 Common Stock 12500 37500 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.59 to $40.32, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. 25% of the shares subject to the option vested on March 30, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. 25% of the shares subject to the option vested on June 9, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. 50% of the shares subject to the option vested on September 1, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. 1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. 1/4th of the shares subject to the option shall vest on June 1, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter. /s/ Peter Maag, as attorney-in-fact for Sasha King 2019-06-21